4//SEC Filing
Rodino-Klapac Louise 4
Accession 0000950170-24-129454
CIK 0000873303other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 8:00 PM ET
Size
5.2 KB
Accession
0000950170-24-129454
Insider Transaction Report
Form 4
Rodino-Klapac Louise
Head of R&D, CSO
Transactions
- Tax Payment
Common Stock
2024-11-18$102.89/sh−4,558$468,973→ 67,630 total
Footnotes (2)
- [F1]Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on November 16, 2021.
- [F2]Amount of Securities Beneficially Owned includes 47 shares purchased under the Company's registered Employee Stock Purchase Plan on August 30, 2024.
Documents
Issuer
Sarepta Therapeutics, Inc.
CIK 0000873303
Entity typeother
Related Parties
1- filerCIK 0001836218
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 8:00 PM ET
- Size
- 5.2 KB